Small molecule drugs Currently, there are 2 small molecule drugs targeting GCGR in clinical development: PegBios GCGR -only agonist PB-722 and the Tianjin Instituteof Pharmaceutical Researchs GCGR x GLP-1R dual agonist TY-751.Bothof these drugs have had their clinical trial applications accepted for review
Gonadotropins Increased GH and IGF1 levels can influence gonadotropin secretion
Increased physical activity: Patients experiencing improved glycemic control and weight loss often increase their physical activity levels
Manufactured in a facility that uses ingredients derived from milk (including lactose), soy, peanuts, other nuts, sesame seeds, cereals containing gluten, eggs, crustaceans, and fish
Time to reperfusion therapy in patients with ST-segment elevation myocardial infarction (STEMI)